Monday, January 4, 2021

Serum, Bharat Biotech vaccines get restricted use approval from DCGI

While the Oxford-AstraZeneca vaccine made by Serum Institute here has 70.42% efficacy, Bharat Biotech's still does not have efficacy data as trials are underway in India

from Today's Paper https://ift.tt/2Muz9hy
via
By at
Labels: ,

No comments:

Post a Comment

If you have any doubts please let me know!

Subscribe to: Post Comments (Atom)

India's low score on GVC a starting point for recovery from pandemic: AIIB

India rated 7.4 percentage points below the average global value chain participation rate for emerging economies from Today's Paper ht...